Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety Outcomes”

627 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 627 results

Not applicableStudy completedNCT01009905
What this trial is testing

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

Who this might be right for
Growth Hormone DisorderPituitary DwarfismHypopituitarism
Novo Nordisk A/S 22,960
Not applicableLooking for participantsNCT06532929
What this trial is testing

Sport Surgery Products Outcomes - A Post-market Follow-up

Who this might be right for
Sport Surgery
Teknimed 390
Testing effectiveness (Phase 2)UnknownNCT05311579
What this trial is testing

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Who this might be right for
Ovarian CarcinomaSurvival OutcomesAdverse Events+6 more
Lei Li 36
Testing effectiveness (Phase 2)UnknownNCT05311566
What this trial is testing

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Who this might be right for
Cervical CarcinomaChemoradiotherapyAnti-programmed Cell Death Receptor 1+6 more
Lei Li 92
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Post-approval studies (Phase 4)Study completedNCT00672477
What this trial is testing

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Who this might be right for
Opioid-Induced Constipation
Bausch Health Americas, Inc. 237
Large-scale testing (Phase 3)Study completedNCT02292784
What this trial is testing

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

Who this might be right for
Obstetric Labour, Premature
GlaxoSmithKline 98
Not applicableNot Yet RecruitingNCT03776006
What this trial is testing

Registry: TPLA for LUTS

Who this might be right for
Lower Urinary Tract SymptomsBenign Prostate HyperplasiaBenign Prostatic Hypertrophy With Outflow Obstruction
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 500
Not applicableEnrolling By InvitationNCT03404778
What this trial is testing

Comprehensive Reverse Shoulder Data Collection

Who this might be right for
Arthropathy of Shoulder RegionGrossly Deficient Rotator CuffOsteoarthritis of the Shoulder+2 more
Zimmer Biomet 175
Not applicableStudy completedNCT04173442
What this trial is testing

Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy

Who this might be right for
Atopic Dermatitis (AD)Asthma
Regeneron Pharmaceuticals 581
Not applicableUnknownNCT02452879
What this trial is testing

Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study

Who this might be right for
Overactive Bladder
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 180
Post-approval studies (Phase 4)Study completedNCT01534182
What this trial is testing

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 298
Post-approval studies (Phase 4)Looking for participantsNCT07266558
What this trial is testing

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Very early researchLooking for participantsNCT06617949
What this trial is testing

Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.

Who this might be right for
Substance Use Disorder (SUD)
Medical College of Wisconsin 20
Not applicableLooking for participantsNCT05868863
What this trial is testing

Percutaneous Cementoplasty With or Without Screw Fixation

Who this might be right for
Interventional Radiology
Centre Hospitalier Universitaire de Saint Etienne 40
Not applicableStudy completedNCT05351658
What this trial is testing

Safety and Effectiveness of the External Fastening System for Temporary Active Fixation Pacemakers (TEMPACE)

Who this might be right for
ArrythmiaBradycardia
ICU Medical Technologies S.L. 30
Not applicableStudy completedNCT04700735
What this trial is testing

Cross Therapy Registry - Edema - US

Who this might be right for
Edema Leg
Firstkind Ltd 83
Not applicableActive Not RecruitingNCT04642508
What this trial is testing

The PreQ-20 TRIAL, a Prospective Cohort Study of Patients Undergoing Prepectoral Breast Reconstruction

Who this might be right for
Breast CancerQuality of LifeSurgery--Complications
University Hospital A Coruña 81
Post-approval studies (Phase 4)Active Not RecruitingNCT07109297
What this trial is testing

Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

Who this might be right for
RSV Immunization
Sanofi 110
Load More Results